< Back to previous page
Researcher
Rosanne Janssens
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Sep 2016 → Today
Projects
1 - 2 of 2
- Evidence-based patient decision aids to support shared decision making in BelgiumFrom10 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Patient Preferences in Drug Development and Evaluation: Issues and RecommendationsFrom3 Oct 2016 → 20 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 17
- Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy(2021)
Authors: Rosanne Janssens, Elise Schoefs, Kristiaan Nackaerts, Isabelle Huys
- Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting(2021)
Authors: Rosanne Janssens, Elise Schoefs, Kristiaan Nackaerts, Herbert Decaluwé, Paul De Leyn, Isabelle Huys
- Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study(2021)
Authors: Rosanne Janssens, Elise Schoefs, Martina Vandebroek, Michel Delforge, Steven Simoens, Isabelle Huys
- What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences(2021)
Authors: Rosanne Janssens, Kristiaan Nackaerts, Isabelle Huys
- Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients(2021)
Authors: Rosanne Janssens, Kristiaan Nackaerts, Isabelle Huys
- Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population(2021)
Authors: Rosanne Janssens, Elise Schoefs, Isabelle Huys
Pages: 2509 - 2517 - Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy(2020)
Authors: Rosanne Janssens
- A future for regulatory science in the European Union: the European Medicines Agency's strategy(2020)
Authors: Rosanne Janssens
Pages: 293 - 294 - Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey(2020)
Authors: Rosanne Janssens, Eline van Overbeeke
- Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review(2019)
Authors: Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Steven Simoens